Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

Recent & Breaking News (CSE:BRAX)

Braxia Scientific Corp. Comments on Prospective Class Proceeding

Canada NewsWire May 3, 2021

Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities

PR Newswire May 3, 2021

IIROC Trade Resumption - SHRM

Canada NewsWire April 23, 2021

Champignon Brands Announces Revocation of Cease Trade Orders

Canada NewsWire April 22, 2021

Champignon Brands Announces Filing of Listing Statement

Canada NewsWire March 26, 2021

Champignon Brands Restates Financial Statements and MD&A Files Listing Statement

Canada NewsWire March 11, 2021

/C O R R E C T I O N from Source -- Champignon Brands Inc./

Canada NewsWire March 11, 2021

Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement

Canada NewsWire February 17, 2021

Dr. Roger McIntyre Announces Changes to the Board of Champignon Brands Inc.

Canada NewsWire February 4, 2021

New Rapid mood Screener (RMS) Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need

Canada NewsWire February 3, 2021

Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Canada NewsWire January 25, 2021

Marijuana Biotech Could Be The Most Exciting Industry Of 2021

Livemoney January 21, 2021

Champignon Brands Announces New CFO and New General Counsel

Canada NewsWire January 11, 2021

Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life

Canada NewsWire January 8, 2021

Champignon Brands Updates Investors on Changes at the Top

Canada NewsWire November 24, 2020

Champignon Brands Provides Update on Continuous Disclosure Review

Canada NewsWire October 29, 2020

IIROC Trading Halt - SHRM

Canada NewsWire October 28, 2020

Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

Canada NewsWire October 5, 2020

Champignon Provides Update on Disclosure Review

GlobeNewswire September 15, 2020

Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

GlobeNewswire August 27, 2020